General Info

Shire Specialty Pharmaceuticals is a division of Shire, which offers products under the VYVANSE, DAYTRANA, ADDERALL, FOSRENOL, AGRYLIN, ELAPRASE and PENTASA brand names for the treatment attention deficit hyperactivity disorder. The division sells its products to several pharmaceutical wholesale distributors and pharmacies in the United States and Europe. Founded in 1994, Shire is one of the leading specialty biopharmaceutical companies that focuses on meeting the needs of specialist physicians in Pennsylvania. The parent company has a staff of more than 1,600 employees. Shire s subsidiaries include Shire Human Genetic Therapies UK Limited, Shire Human Genetic Therapies Securities Corporation, Shire Investments & Finance (U.K.) Company, Shire Pharmaceutical Contracts Limited and Shire Intellectual Property 2 SRL.